This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
secondary antibody
product name :
Goat Anti-Horse IgA Secondary Antibody LS-C68413
catalog :
LS-C68413
product information
AntibodyID :
69039
AntibodyName :
LS-C68413
TargetSpecies :
Horse
Host Species :
Goat
Product Name :
Goat Anti-Horse IgA Secondary Antibody LS-C68413
Specificity :
Recognizes equine IgA. No cross-reactivity with other equine immunoglobulin classes is seen in immunoelectrophoresis.
ClonalityDesc :
Polyclonal
AntibodyModification :
Unconjugated
PresentationDesc :
PBS, pH 7.2, 0.1% Sodium Azide
ImmunogenType :
Purified protein
ImmunogenDesc :
Purified equine IgA.
PurificationDesc :
Affinity purified
IsotypeName :
IgG
Gene :
Horse IgA
Reactivity :
Horse
Usage :
ELISA (1:100 - 1:1000), IE
ShortWebDescription :
Horse IgA antibody LS-C68413 is an unconjugated goat polyclonal antibody. Validated for ELISA and IE.
UsageText :
Suitable for use in ELISA and Immunoelectrophoresis. ELISA: 1:100-1:1000.
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.